NYSE · FC

Franklin Covey Company

$21.70 +$1.10 (+5.34%) 1D Market open

Key Metrics

$232.65M
Market cap
P/E · TTM
$263.43M
Revenue · TTM
−$1.48M
Net income
EPS · TTM $-0.13
Dividend yield
Free cash flow $19.29M
Beta · 1Y 1.05
EBITDA · TTM $6.98M
Gross margin 75.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 2
    The stock moved -12.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 2
  • Apr 2
    The stock moved +44.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 2
  • Mar 13
    From its Feb 2 high, the share price fell 44%.

    Peak close $20.65 on Feb 2; trough close $11.54 on Mar 13. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -44%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$232.65M
Enterprise value
Shares outstanding11.3M
52-wk range$11.16 – $26.81
Avg volume · 20D87.7K
Net cash
Book value / share$3.69
IndustryServices-Management Services
ExchangeNYSE
About Franklin Covey Company
IPO dateJun 9, 1992
Employees1120

Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.88
P/FCF12.06
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 75.1%
Operating 1.0%
Net -0.6%
FCF 7.3%
ROE / ROIC -2.4% · -4.8%

Financial Health

Current ratio0.66
Quick ratio0.61
Debt / equity
Debt / EBITDA
Net cash
Working capital−$48.32M

Cash Flow · TTM

Operating CF $27.41M
Capex −$8.12M
Free cash flow $19.29M
Buybacks $31.50M
Dividends paid
Shareholder yield 13.5%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

2.9
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-05-31 · computed by TickerWolf from SEC filings